Search This Blog

Wednesday, July 25, 2018

Anika Therapeutics reports Q2 EPS 68c, consensus 33c


Reports Q2 revenue $30.55M, consensus $27.9M.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)